There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.

The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial ...

Vektor Medical, a medical technology company transforming standard ECG data into actionable insights that guide arrhythmia ...

Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...